文献速递炎症性肠病

炎症性肠病患者出院后静脉血栓栓塞的临床预测模型

A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2019-05-08

该研究基于2009至2016年机构出院数据库,纳入2161例次炎症性肠病住院患者出院记录,回顾性评估出院后3个月内静脉血栓栓塞(VTE)风险因素,并构建床旁预测模型。多变量分析显示年龄>45岁(OR 3.76;95% CI 1.80-7.89)和多次入院(OR 2.62;95% CI 1.34-5.11)与VTE风险独立相关。最终模型纳入年龄>45岁、多次入院、重症监护室入住、住院时间>7天和中心导管,乐观校正c统计量为0.70(95% CI 0.58-0.77);若仅对高风险组进行延长血栓预防,可避免92%出院患者的延长预防,漏诊率为1.6%(32/1982例次出院)。

要点

  • 2161例次IBD出院中66例次(3%)在住院6个月内发生VTE,中位发生时间37天(范围3-182天)。
  • 年龄>45岁(OR 3.76;95% CI 1.80-7.89)和多次入院(OR 2.62;95% CI 1.34-5.11)与VTE风险独立相关。
  • 最终模型乐观校正c统计量0.70(95% CI 0.58-0.77),仅对高风险组延长预防可避免92%出院患者的延长预防,漏诊率1.6%(32/1982例次出院)。

核心结论

  • 炎症性肠病患者出院后仍存在VTE风险,该模型可能帮助临床医生分层判断哪些患者将从延长血栓预防中获益最大。

研究设计与样本

  • 研究为回顾性队列分析,从机构出院数据库识别2009至2016年住院的炎症性肠病患者,通过病历回顾评估VTE,采用单变量和多变量逻辑回归确定出院后3个月内VTE的危险因素,并使用单变量分析中P<0.05的变量构建床旁模型,通过bootstrap方法进行内部验证。

主要发现

  • 2161例次符合条件出院中,66例次(3%)在住院6个月内发生VTE,中位发生时间为37天(范围3-182天)。
  • 多变量分析显示年龄>45岁(OR 3.76;95% CI 1.80-7.89)和多次入院(OR 2.62;95% CI 1.34-5.11)与VTE风险独立相关。
  • 最终模型纳入年龄>45岁、多次入院、重症监护室入住、住院时间>7天和中心导管,乐观校正c统计量为0.70(95% CI 0.58-0.77)。
  • 若将治疗限制于高风险组,可避免92%出院患者的延长血栓预防,漏诊率为1.6%(32/1982例次出院)。

关键数值与推荐

  • 年龄>45岁与VTE风险的OR为3.76(95% CI 1.80-7.89)。
  • 多次入院与VTE风险的OR为2.62(95% CI 1.34-5.11)。
  • 最终模型乐观校正c统计量为0.70(95% CI 0.58-0.77)。
  • 限制治疗于高风险组时,可避免92%出院患者的延长血栓预防,漏诊率为1.6%(32/1982例次出院)。

临床怎么用

  • 作者认为该模型可能帮助临床医生分层判断哪些炎症性肠病患者将从延长血栓预防中获益最大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with inflammatory bowel disease (IBD) are at increased risk of venous thromboembolism (VTE) during hospitalisation and potentially post-discharge. AIMS: To determine the incidence and risk factors for post-discharge VTE in IBD patients and create a point of care predictive model to assess VTE risk. METHODS: Hospitalised IBD patients were identified from our institutional discharge database between 2009 and 2016, and were assessed for VTE by chart review. Risk factors for VTE within 3 months of discharge were determined by univariable and multivariable logistic regression. A point of care model was created using variables from the univariate analysis with P < 0.05, and internally validated by bootstrap methods. RESULTS: Sixty-six of 2161 eligible discharges (3%) were associated with VTE within 6 months of hospitalisation. The median time to event was 37 days (range 3-182 days). On multivariable analysis age >45 years (OR 3.76; 95% CI 1.80-7.89) and multiple admissions (OR 2.62; 95% CI 1.34-5.11) were independently associated with VTE risk. Our final model incorporated age >45 years, multiple admissions, intensive care unit admission, length of admission >7 days and central catheter and was able to discriminate between discharges associated with and without VTE (optimism-corrected c-statistic, 0.70; 95% CI 0.58-0.77). By limiting treatment to a high-risk group, extended thromboprophylaxis could be avoided in 92% of discharges with a miss rate of 1.6% (32/1982 discharges). CONCLUSION: Patients with IBD remain at risk of VTE after hospital discharge. Our model may help clinicians stratify which patients will benefit most from extended thrombophrophylaxis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. McCurdy JD, Israel A, Hasan M, et al. A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019. PMID: 31066471. doi:10.1111/apt.15286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。